J.M. Gandon

939 total citations
22 papers, 717 citations indexed

About

J.M. Gandon is a scholar working on Cognitive Neuroscience, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, J.M. Gandon has authored 22 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cognitive Neuroscience, 5 papers in Pharmacology and 5 papers in Psychiatry and Mental health. Recurrent topics in J.M. Gandon's work include Blood Pressure and Hypertension Studies (4 papers), Treatment of Major Depression (4 papers) and Neural and Behavioral Psychology Studies (4 papers). J.M. Gandon is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Treatment of Major Depression (4 papers) and Neural and Behavioral Psychology Studies (4 papers). J.M. Gandon collaborates with scholars based in France, Switzerland and Italy. J.M. Gandon's co-authors include H. Allain, Alain Lieury, I. F. Moseley, O Sabouraud, M. T. Iba-Zizen, Gilles Edan, M. Clanet, J.-C. Froment, E. A. Cabanis and O. Lyon‐Caen and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Neurology Neurosurgery & Psychiatry and Psychopharmacology.

In The Last Decade

J.M. Gandon

22 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Gandon France 12 301 167 146 113 96 22 717
Sen-yang Lang China 17 89 0.3× 61 0.4× 56 0.4× 228 2.0× 56 0.6× 39 681
S. Gauthier France 14 112 0.4× 124 0.7× 81 0.6× 164 1.5× 46 0.5× 37 604
Jonathan E. Walker United States 17 121 0.4× 167 1.0× 27 0.2× 224 2.0× 189 2.0× 30 791
Vittorio Govoni Italy 19 136 0.5× 584 3.5× 60 0.4× 186 1.6× 185 1.9× 35 1.1k
Cecília Rajda Hungary 20 374 1.2× 95 0.6× 83 0.6× 107 0.9× 15 0.2× 52 919
Brian Hunter United States 11 81 0.3× 118 0.7× 37 0.3× 141 1.2× 64 0.7× 18 843
Arie Weinstock United States 14 102 0.3× 72 0.4× 30 0.2× 364 3.2× 92 1.0× 35 793
Naji Riachi Lebanon 16 177 0.6× 285 1.7× 25 0.2× 143 1.3× 37 0.4× 39 700
Antonio Martínez‐Salio Spain 14 154 0.5× 197 1.2× 19 0.1× 288 2.5× 84 0.9× 36 784
Tina Roostaei United States 14 177 0.6× 90 0.5× 21 0.1× 90 0.8× 97 1.0× 18 717

Countries citing papers authored by J.M. Gandon

Since Specialization
Citations

This map shows the geographic impact of J.M. Gandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Gandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Gandon more than expected).

Fields of papers citing papers by J.M. Gandon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Gandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Gandon. The network helps show where J.M. Gandon may publish in the future.

Co-authorship network of co-authors of J.M. Gandon

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Gandon. A scholar is included among the top collaborators of J.M. Gandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Gandon. J.M. Gandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allain, H., et al.. (2003). Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 165(4). 419–429. 24 indexed citations
2.
Gandon, J.M. & H. Allain. (2002). Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. British Journal of Clinical Pharmacology. 54(1). 51–58. 61 indexed citations
3.
Denolle, Thierry, et al.. (2002). Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients. Fundamental and Clinical Pharmacology. 16(6). 527–535. 23 indexed citations
4.
Patat, Alain, et al.. (1999). Effects of tiapride on electroencephalograms and cognitive functions in the elderly. International Clinical Psychopharmacology. 14(4). 199–208. 9 indexed citations
5.
Allain, H., et al.. (1999). Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 10(3). 181–185. 28 indexed citations
6.
Schück, Stéphane, et al.. (1998). Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundamental and Clinical Pharmacology. 12(4). 463–467. 5 indexed citations
7.
Allain, H., et al.. (1998). Use of zolpidem 10 mg as a benzodiazepine substitute in 84 patients with insomnia. Human Psychopharmacology Clinical and Experimental. 13(8). 551–559. 11 indexed citations
8.
Edan, Gilles, David Miller, M. Clanet, et al.. (1997). Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.. Journal of Neurology Neurosurgery & Psychiatry. 62(2). 112–118. 314 indexed citations
9.
Bellissant, Éric, Thierry Denolle, Daniel G. Bichet, et al.. (1996). Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 232–242. 24 indexed citations
10.
Curet, O., et al.. (1996). Measurement of 3,4 Dihydroxyphenyl Ethylene Glycol (DOPEG) in Plasma by High Performance Liquid Chromatography with Electrochemical Detection. Journal of Liquid Chromatography & Related Technologies. 19(19). 3119–3124. 3 indexed citations
11.
Allain, H., Serge Belliard, Alain Lieury, et al.. (1996). [Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss].. PubMed. 51(2). 155–62. 4 indexed citations
12.
Gandon, J.M., F. Le Coz, Marc Enslen, et al.. (1996). Determination of the maximal tolerated dose of a new acute oral caffeine formulation in healthy volunteers.. Clinical Pharmacology & Therapeutics. 59(2). 179–179. 1 indexed citations
13.
14.
Allain, H., et al.. (1995). Explicit and procedural memory in Parkinson's disease. Biomedicine & Pharmacotherapy. 49(4). 179–186. 20 indexed citations
15.
Gandon, J.M., et al.. (1995). P-2-8 Antidepressant effects of milnacipran in the learned helplessness test in rats. European Neuropsychopharmacology. 5(3). 276–276. 7 indexed citations
16.
Patat, Alain, J.M. Gandon, Geneviève Durrieu, et al.. (1995). Effects of single and multiple doses of a new reversible MAO‐A inhibitor, befloxatone, on psychomotor performance and memory in healthy subjects. Human Psychopharmacology Clinical and Experimental. 10(2). 111–125. 10 indexed citations
17.
Delumeau, Jean-Christophe, Danièle Bentué‐Ferrer, J.M. Gandon, et al.. (1994). Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases. PubMed. 41. 259–266. 18 indexed citations
18.
Allain, H., et al.. (1993). Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.. PubMed. 15(3). 549–58. 65 indexed citations
19.
Allain, H., et al.. (1992). Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology. 106(S1). S56–S61. 52 indexed citations
20.
Allain, H., et al.. (1992). A DOUBLE BLIND STUDY OF THE EFFECT OF ZOLPIDEM IN CHRONIC INSOMNIAC OUTPATIENTS IN SUBSTITUTION OF TRIAZOLAM.. Clinical Neuropharmacology. 15. 77B–77B. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sen-yang Lang Breakdown of academic impact, for papers by S. Gauthier Breakdown of academic impact, for papers by Jonathan E. Walker Breakdown of academic impact, for papers by Vittorio Govoni Breakdown of academic impact, for papers by Cecília Rajda Breakdown of academic impact, for papers by Brian Hunter Breakdown of academic impact, for papers by Arie Weinstock Breakdown of academic impact, for papers by Naji Riachi Breakdown of academic impact, for papers by Antonio Martínez‐Salio Breakdown of academic impact, for papers by Tina Roostaei
Rankless by CCL
2026